COMMUNIQUÉS West-GlobeNewswire

Brain Scientific Will Present EEG Devices To Industry Professionals at ASET 2019 Annual Conference
16/08/2019
NEW YORK, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Brain Scientific Inc. (OTC:BRSF) (“Brain Scientific” or “Company”), a medical device company combining brain analysis software with wireless sensor technologies for [...]
Immuron to Commence Non-Deal Investor Roadshow
16/08/2019
MELBOURNE, Australia, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunoglobulin therapeutics for [...]
Periodic update on transaction details related to Philips’ share repurchases
16/08/2019
August 16, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported that in the period from August 9, 2019 up to and including August 15, 2019 a total of 492,820 of its own common shares [...]
NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY – 30 JUNE 2019 (UNAUDITED)
16/08/2019
Company announcement, Helsinki, 16 August 2019 at 9:00 am Highlights, January – June 2019 Focused on executing our depression-led therapy strategy. Good progress with a total of eight new NBT ® systems installed in [...]
XYLONIX SIGNS MOU WITH BIOGEMEX TO CO-DEVELOP A PREDICTIVE CANCER IMMUNOTHERAPY TREATMENT RESPONSE DIAGNOSTIC
16/08/2019
Singapore, Aug. 16, 2019 (GLOBE NEWSWIRE) -- XYLONIX SIGNS MOU WITH BIOGEMEX TO CO-DEVELOP A PREDICTIVE CANCER IMMUNOTHERAPY TREATMENT RESPONSE DIAGNOSTIC XDX-01, a novel, point-of-care pre-treatment diagnostic, has [...]
FDA approves Roche’s RozlytrekTM (entrectinib) for people with ROS1-positive, metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumours
16/08/2019
First FDA-approved treatment designed to target both ROS1 and NTRK that also shows response in cancer that has spread to the brain Roche’s first FDA-approved tumour-agnostic medicine Basel, 16 August 2019 - Roche (SIX: [...]
AgraFlora Organics International Inc. annonce avoir le soutien des actionnaires d’Eviana concernant l'offre publique d’achat
16/08/2019
VANCOUVER, Colombie-Britannique, 15 août 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (« AgraFlora » ou la « Société ») (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) , annonce que, suite à son [...]
Plus Therapeutics Reports Q2 2019 Financial and Business Results
16/08/2019
AUSTIN, Texas, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”) today announced Q2 2019 financial results and provided updates on corporate activities. Q2 2019 net loss from [...]
North American Partners in Anesthesia (NAPA) Expands Anesthesia Services in Connecticut with Day Kimball Healthcare
16/08/2019
NAPA provides high-quality anesthesia and perioperative patient care at four hospitals, two ambulatory surgery centers and seven gastrointestinal centers in Connecticut MELVILLE, N.Y., Aug. 15, 2019 (GLOBE NEWSWIRE) -- [...]
Delcath Systems Announces $9.5 Million Private Placement
16/08/2019
NEW YORK, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCQB: DCTH)) today announced that it has entered into a definitive agreement for gross proceeds of [...]
Bellicum Pharmaceuticals Announces Proposed $53.0 Million Public Offering of Preferred Stock and Warrants with Concurrent Private Placement
15/08/2019
HOUSTON, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Progressive Care Inc. Files an Amended June 30, 2019 Quarterly Report
15/08/2019
MIAMI, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today filed an Amended Quarterly Report for the Quarter ended June 30, 2019. [...]
Predictive Oncology to Report Second Quarter 2019 Financial Results and Provide Company Update on Monday, August 19, 2019
15/08/2019
Conference Call to be held August 19, 2019, at 4:30pm Eastern Time MINNEAPOLIS, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology Inc., (NASDAQ: POAI) (“Predictive Oncology ” or “the Company”) an artificial [...]
FH ORTHO Partners with Red One Medical to Bring Innovation and Surgeon-Focused Solutions to our Active Military Service Members and Nation’s Veterans
15/08/2019
CHICAGO, Aug. 15, 2019 (GLOBE NEWSWIRE) -- FH Ortho Inc. announces a partnership with Service-Disabled Veteran-Owned Small Business, Red One Medical. Red One is a strategic partner with expertise in medical device [...]
AgraFlora Organics International Inc. Announces Shareholder Support for Offer
15/08/2019
VANCOUVER, British Columbia, Aug. 15, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), announces that further to its news [...]
Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering
15/08/2019
San Diego, CA , Aug. 15, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), today announced the closing of its previously announced underwritten public offering of 13, [...]
Medexus Announces DTC Eligibility of its Common Shares in the United States
15/08/2019
MONTREAL, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “ Medexus ”) (TSXV: MDP, OTCQB: PDDPF) is pleased to announce that the Company's common shares traded in the United States, [...]
EUROPEAN MEDICINES AGENCY VALIDATES MARKETING APPLICATION FOR FILGOTINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
15/08/2019
Foster City, Calif. and Mechelen, Belgium – August 15, 2019 22.01 CET – Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Marketing Authorization Application ( [...]
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2019 Financial Results
15/08/2019
Conference Call Scheduled for August 20, 2019 at 11:00 am EASTERN DUBLIN, Ireland, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for [...]

Pages